A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

Paul Shotbolt1 Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King’s College, London, UKCorrespondence[email protected]

Michael Samuel2 Department of Neurology, King’s College Hospital, London, UK;3 East Kent Hospitals NHS Trust, William Harvey Hospital, Ashford, Kent, UK

Chris Fox3 East Kent Hospitals NHS Trust, William Harvey Hospital, Ashford, Kent, UK;4 Kent and Medway NHS and Social Care and Partnership Trust, Kent, UK

Anthony S David1 Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King’s College, London, UK

Pages 327-332 | Published online: 25 May 2009

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BarnesJDavidASVisual hallucinations in Parkinson’s disease: a review and phenomenological surveyJ Neurol Neurosurg Psychiatry20017072773311385004
PubMed Web of Science ®Google Scholar
AarslandDLarsenJPCummingsJLPrevalence and clinical correlates of psychotic symptoms in Parkinson disease; A community-based studyArch Neurol19995659560110328255
PubMed Web of Science ®Google Scholar
GoetzCGStebbinsGTMortality and hallucinations in nursing home patients with advanced Parkinson’s diseaseNeurology1995456696717723953
PubMed Web of Science ®Google Scholar
AarslandDLarsenJPTandbergEPredictors of nursing home placement in Parkinson’s disease: a population-based, prospective studyJ Am Geriatr Soc20004893894210968298
PubMed Web of Science ®Google Scholar
CummingsJLManaging psychosis in patients with Parkinson’s diseaseN Engl J Med199934080180310072418
PubMed Web of Science ®Google Scholar
FactorSAFriedmanJHAtypical antipsychotics in the treatment of drug-induced psychosis in Parkinson’s diseaseMov Disord20001520121110752567
PubMed Web of Science ®Google Scholar
Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. The Parkinson Study GroupN Engl J Med199934075776310072410
PubMed Web of Science ®Google Scholar
PollakPTisonFRascolOClozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow upJ Neurol Neurosurg Psychiatry20047568969515090561
PubMed Web of Science ®Google Scholar
BreierASuttonVKFeltmanPDOlanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s diseaseBiol Psychiatry200252543844512242060
PubMed Web of Science ®Google Scholar
RichSSFriedmanJHOttBRRisperidone in the treatment of psychosis in six patients with Parkinson’s disease and other akinetic-rigid syndromesJ Clin Psychiatry199556125565598530331
PubMed Web of Science ®Google Scholar
NasrallahHABrecherMPaulssonBPlacebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar maniaBipolar Disord2006846747417042884
PubMed Web of Science ®Google Scholar
AtmacaMKulogluMTezcanEQuetiapine is not associated with increase in prolactin secretion in contrast to haloperidolArch Med Res20023356256512505103
PubMed Web of Science ®Google Scholar
ReddySFactorSAMolhoESThe effect of quetiapine on psychosis and motor function in PD patients with and without dementiaMov Disord200217467668112210856
PubMed Web of Science ®Google Scholar
OndoWGTintnerRVoungKDDouble-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson’s diseaseMov Disord20052095896315800937
PubMed Web of Science ®Google Scholar
RabeyJMProkhorovTMiniovitzAEffect of quetiapine in psychotic Parkinson’s disease patients: a double-blind labelled study of 3 months’ durationMov Disord20072231331817034006
PubMed Web of Science ®Google Scholar
KurlanRCummingsJRamanRQuetiapine for agitation or psychosis in patients with dementia and parkinsonismNeurology2007681356136217452579
PubMed Web of Science ®Google Scholar
MorganteLEpifanioASpinaEQuetiapine and clozapine in parkinsonian patients with dopaminergic psychosisClin Neuropharmacol20042715315615319699
PubMed Web of Science ®Google Scholar
MerimsDBalasMPeretzCRater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson’s disease psychosisClin Neuropharmacol20062933133717095896
PubMed Web of Science ®Google Scholar
OverallJGorhamDBrief Psychiatric Rating ScalePsychol Rep196210799812
Web of Science ®Google Scholar
McKeithIGGolaskoDKosakaKConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopNeurology199647111311248909416
PubMed Web of Science ®Google Scholar
FahnSMembers of the UPDRS Development CommitteeUnified Parkinson’s Disease Rating ScaleFahnSMarsdenCDCalneDBRecent developments in Parkinson’s disease198711153163
Google Scholar
CummingsJLMegaMGrayKThe Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementiaNeurology199444230823147991117
PubMed Web of Science ®Google Scholar
FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res1975121891981202204
PubMed Web of Science ®Google Scholar
BrandstaedterDSpiekerSUlmGDevelopment and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson’s diseaseJ Neurol200525291060106615789127
PubMed Web of Science ®Google Scholar
Committee on Safety of Medicines. Latest news. March 9, 2004. Atypical antipsychotic drugs and stroke. Accessed on April 10, 2009. Available from: http://www.info.doh.gov.uk/doh/embroadcast.nsf/vwDiscussionAll
Google Scholar
US Food and Drug Administration (Public Health Advisory). Deaths with antipsychotics in elderly patients with behavioural disturbances. 2005Accessed on April 10, 2009. Available from: http://www.fda.gov/cder/drug/advisory/antipsychotics.htm
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date